Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06430593
Other study ID # 2024- 183
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date May 20, 2024
Est. completion date September 25, 2024

Study information

Verified date May 2024
Source Basaksehir Çam & Sakura City Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

Robotic-assisted laparoscopic surgery has many advantages compared to conventional open surgery, such as less postoperative pain, shorter hospital stays, and faster recovery times. Robot-assisted surgeries require general anesthesia. In our clinic, we routinely apply low-flow anesthesia methods in addition to normal flow methods in many surgical applications, according to clinician preferences. The aim of this study is to determine the effects of low flow (0.5 lt/min) and normal flow (>1 lt/min) anesthesia applications in robotic-assisted laparoscopic surgeries. To compare perioperative hemodynamic and respiratory parameters in terms of inhalation agent and soda lime consumption.


Description:

Robotic surgery is the performance of laparoscopic surgery using a robotic interface. The robotic surgery system used today is called Da Vinci S. In surgeries performed with the help of a robot, the surgeon can work more precisely and with greater maneuverability. Therefore, an operation can be performed that is less traumatic for the patient than other methods.Robotic-assisted laparoscopic surgery has many advantages compared to conventional open surgery, such as less postoperative pain, shorter hospital stays, and faster recovery times. Robot-assisted surgeries require general anesthesia. In these applications, fresh gas flow in anesthesia systems can be made with traditional high, normal or low flow strategies, depending on the preference of the clinicians.Low-flow anesthesia creates a breathing air closer to physiological conditions during anesthesia by heating and humidifying the inhaled gases. In addition, it provides cost advantage by reducing inhalation agent consumption and reduces atmospheric pollution. It is suggested that the use of both fresh gas flow amounts does not pose a safety risk for patients, and that the use of low-flow anesthesia methods should be more widespread due to the advantages it provides. In our clinic, investigators routinely apply low-flow anesthesia methods in addition to normal flow methods in many surgical applications, according to clinician preferences. The aim of this study is to determine the effects of low flow (0.5 lt/min) and normal flow (>1 lt/min) anesthesia applications in robotic-assisted laparoscopic surgeries. To compare perioperative hemodynamic and respiratory parameters in terms of inhalation agent and soda lime consumption.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 68
Est. completion date September 25, 2024
Est. primary completion date September 25, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria: - Ages 18-75 - ASA I,II - Patients undergoing robotic-assisted laparoscopic surgery Exclusion Criteria: - ASA III,IV,V - Those with serious cardiac, respiratory, hepatic, renal disease - People with mental status disorders, psychiatric illnesses - Patients with hearing problems and glaucoma - Desire to be out of work

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
low-flow anesthesia
0,5 l/min >1 l/min

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Basaksehir Çam & Sakura City Hospital

Outcome

Type Measure Description Time frame Safety issue
Primary Hemodynamic Parameters It was aimed to compare heart rates in patients undergoing low flow (0.5 lt/min) and normal flow (>1 lt/min) anesthesia. Perioperative period(approximately 3-6 hours)
Primary Hemodynamic Parameters It was aimed to compare blood pressure in patients undergoing low flow (0.5 lt/min) and normal flow (>1 lt/min) anesthesia. Perioperative period(approximately 3-6 hours)
Primary Respiratory parameters It was aimed to compare oxygen saturation in patients undergoing low flow (0.5 lt/min) and normal flow (>1 lt/min) anesthesia. Perioperative period(approximately 3-6 hours)
Primary Respiratory parameters It was aimed to compare endtidal carbon dioxide in patients undergoing low flow (0.5 lt/min) and normal flow (>1 lt/min) anesthesia. Perioperative period(approximately 3-6 hours)
Primary Inhalation agent (sevoflurane) consumption It was aimed to compare inhalation agent (sevoflurane) consumption (lt) in patients undergoing low flow (0.5 lt/min) and normal flow (>1 lt/min) anesthesia. Perioperative period(approximately 3-6 hours)
Primary Soda lime consumption It was aimed to compare soda lime consumption in patients undergoing low flow (0.5 lt/min) and normal flow (>1 lt/min) anesthesia.
Soda lime consumption refers to the number of changes of the soda lime canister.
Perioperative period(approximately 3-6 hours)
See also
  Status Clinical Trial Phase
Completed NCT01439152 - Phase I Study to Determine the Maximum Tolerable Dose of BAY94-9343 in Patients With Advanced Solid Tumors. Phase 1
Recruiting NCT05615246 - Exactech Humeral Reconstruction Prosthesis of Shoulder Arthroplasty PMCF (HRP)
Active, not recruiting NCT06015009 - Symptom Management App for Children at the Early Stage of Cancer Survivorship and Their Caregivers N/A
Active, not recruiting NCT03298100 - Risk Scoring Model for Endometrial Cancer
Recruiting NCT05055609 - Open-Label, Dose-Escalation With Expansion to Assess the Safety, Tolerability, and PK of TRE-515 in Subjects With Solid Tumors Phase 1
Not yet recruiting NCT04324320 - Psychological Distress in Outpatient Oncological Rehabilitation
Completed NCT00588289 - Long Term Follow-Up of Patients on Children's Cancer Group Protocols- (CCG-LTF1) FOLLOW-UP DATA N/A
Recruiting NCT06222801 - The 1st Tumor CytokinoTherapy Database (TCTD-1)
Recruiting NCT03831633 - Comparative Effectiveness of AKYNZEO® and Standard of Care (Including EMEND®) for the Prevention of Nausea and Vomiting (CINV) in Cancer Patients Phase 4
Completed NCT04914702 - Feasibility and Comparison of Continuously Monitored Vital Signs in Pediatric Patients With Cancer.
Recruiting NCT05198570 - Pharmacokinetics of Intravenous Acyclovir in Oncologic Paediatric Patients
Recruiting NCT05712174 - A Study of [18]F-PSMA-1007 in Patients With Known or Suspected Metastatic Prostate Cancer Phase 2
Recruiting NCT03832062 - Value of Analysing Under-utilised Leftover Tissue (VauLT)
Completed NCT03988777 - Magnetic Seed Localisation for Nonpalpable Breast Lesions
Recruiting NCT06031233 - Evaluating the Safety of Shortened Infusion Times for dIfferent Oncological Immunotherapie Phase 4
Enrolling by invitation NCT04019119 - Digital Intervention for the Modification of Lifestyles (iGame) N/A
Not yet recruiting NCT05926362 - Capillary-Venous Paired Data Collection
Recruiting NCT05686213 - ExeNTrO: Exercise During Neoadjuvant Chemoradiation Treatment to Improve Rectal and Esophageal Cancer Outcome - Pilot Trial Phase 2
Recruiting NCT05510856 - Comparative Clinical Study Evaluating the Possible Efficacy of Duloxetine, Gabapentin and Lacosamide on Oxaliplatin-Induced Peripheral Neuropathy in Cancer Patients Phase 4
Completed NCT04180306 - PEWS Implementation in an LMIC Setting N/A